Fujirebio Diagnostics Inc. has won Japanese regulatory approval for a rapid test kit for the virus that causes COVID-19, with sales of the kit starting today. This is the first antigen test kit for SARS-CoV-2 approved in the country and will be used to bolster its testing rate.
The Fujirebio test takes under 30 minutes to process, compared with the four to six hours required for polymerase chain...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?